Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda ; volume:9 ; number:1 ; day:03 ; month:6 ; year:2009 ; pages:1-11 ; date:12.2009
BMC infectious diseases ; 9, Heft 1 (03.6.2009), 1-11, 12.2009
- Creator
-
Ahoua, Laurence
- Contributor
-
Guenther, Gunar
Pinoges, Loretxu
Anguzu, Paul
Chaix, Marie-Laure
Le Tiec, Clotilde
Balkan, Suna
Olson, David
Olaro, Charles
Pujades-Rodríguez, Mar
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-9-81
- URN
-
urn:nbn:de:1111-2016030254056
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ahoua, Laurence
- Guenther, Gunar
- Pinoges, Loretxu
- Anguzu, Paul
- Chaix, Marie-Laure
- Le Tiec, Clotilde
- Balkan, Suna
- Olson, David
- Olaro, Charles
- Pujades-Rodríguez, Mar
- SpringerLink (Online service)
Other Objects (12)
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada